← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Sep 1, 2026

HYPERION DEFI, INC. (HYPD)

Healthcare • NASDAQ

$3.42

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

25.0/100

POOR BUSINESS

HYPERION DEFI, INC. (HYPD) scores 25/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full HYPD quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

Margin of Safety unavailable — insufficient data for the owner-earnings DCF.

BRINA GAP ↗

Is the market underestimating or overestimating what this business is capable of going forward?

-8.4%

Market Overestimates

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full HYPD valuation analysis · → View full HYPD Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):POOR (9.8%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.02x)

Operating Margin (Operational Efficiency):EXCELLENT (311.1%)

Return on Capital (Capital Efficiency):CRITICAL (3.6%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

HYPERION DEFI, INC. (HYPD) stock report — Zyberno Score 25/100 (POOR BUSINESS). Full financial analysis on Zyberno.

According to Zyberno's DCF model, HYPERION DEFI, INC. (HYPD) shows a Brina Gap of -8.4%, which weakens the case: based on the company's ROIC (3.6%) and reinvestment rate (-334.3%), the business can fundamentally grow at -11.9% — but the current enterprise value implies the market expects -3.5%.

Over the trailing twelve months, HYPD generated -$23.95M in Owner Earnings. Capital was deployed as follows: $305.09K invested in capital expenditures. Reinvestment rate: -334.3%.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:3.42

Market Cap:$48.47M

Valuation Multiples (3)

P/B Ratio:0.48x

P/S Ratio:34.25x

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$39.31M

Ev Ebitda Ratio:7.11x

Price Action & Momentum (3)

12-1 Momentum:

-47.9% (3th pctile)

📈 Click to view full HYPD Momentum analysis →

Momentum Percentile:3 / 100

% of 52-Week High:22.8%

B. Profitability Assessment

Return Metrics (7)

ROE:

9.8%

📊 Click to view full HYPD ROE analysis →

ROA:8.4%

Roic:

3.6%

📊 Click to view full HYPD ROIC analysis →

Reinvestment Rate:-334.3%

Fundamental Growth Rate (g):-11.9%

Market-Implied Growth Rate:-3.5%

Brina Gap:

-8.4%

☷ Click to view full HYPD Brina Gap analysis →

Margin Analysis (3)

Operating Margin Ttm:311.1%

Net Margin Ttm:469.9%

Ebitda Margin:390.8%

TTM Performance (3)

Gross Margin Ttm:78.6%

Operating Margin Ttm:311.1%

Net Margin Ttm:469.9%

Yield Metrics (2)

Earnings Yield:-$149.64

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

+0.19

📊 Click to view full HYPD Earnings Surprise analysis →

EPS Surprise vs Expected:131.5%

Latest Earnings Filed:2026-08-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-25.9%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.34x

Quick Ratio:1.80x

Cash Ratio:1.75x

Leverage Analysis (3)

Debt To Equity Ttm:0.02x

Debt-to-Equity Ratio:0.02x

Debt To Ebitda:0.09x

Coverage Ratios (2)

Interest Coverage Ratio:-51.48x

Times Interest Earned:-51.48

Capital Structure (4)

Working Capital:7,400,075.00

Cash And Cash Equivalents:9,637,216.00

Long Term Debt:$55.65K

Net Debt:-$9.16M

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.42M

Linear Growth: -25.9%

📊 Click to view full HYPD Revenue analysis & methodology →

Cost Of Revenue Ttm:$303.29K

Profitability Breakdown (2)

Gross profit TTM: $1.11M

Linear Growth: -42.1%

📊 Click to view full HYPD Gross Profit analysis & methodology →

$4.40M

Bottom Line Performance (3)

$6.65M

Income Before Tax:$0.00

Ebitda Ttm:5,531,224.00

Operating Expenses (5)

Operating Expenses:-3,305,318.00

R And D Expense:908,064.00

Sga Expense:15,536,868.00

Income Tax Expense:-$30.94K

Interest Expense:907,508.00

Expense Ratios (3)

R And D To Revenue Percentage:253.9%

Sga To Revenue Percentage:4,343.6%

Ebitda Margin:390.8%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$113.14M

Current Assets:$12.91M

Ppe Net:22,959.00

Goodwill:0.00

Intangible Assets:$25.72M

Liability Structure (4)

Total Liabilities:11,204,147.00

Current Liabilities:5,508,802.00

Long Term Debt:$55.65K

Short Term Debt:$417.59K

Equity & Capital (3)

Equity:$101.93M

Retained Earnings:-$200.83M

Common Stock:600,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00

Inventory:2,967,256.00

Accounts Payable:139,114.00

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:1,632,349.00

C. Cash Flow Analysis

Operating Activities (2)

-$14.52M-$14.83M

Investment Activities (2)

Investing Cash Flow:-$1.47M

Capital Expenditures Ttm:305,085.00

Financing Activities (3)

Financing Cash Flow:$6.61M

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:4,000,000.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:1,128,449.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-4.00

-$4.13

Earnings Per Share Ttm:$0.47

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.10

Operating Cash Flow Per Share:-$1.04

Book Value & Capital (2)

Book Value Per Share:$7.19

Cash Per Share:0.68

Dividend Policy (1)

Dividend Payout Ratio:0.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.02x

Working Capital Turnover Ttm:0.19x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x

Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:0.10x

Days Inventory Outstanding Ttm:3,571.00

Payables & Cash Cycle (2)

Days Payable Outstanding:167.42

Cash Conversion Cycle:2,404.58

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00

Quality Score:40.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (1)

-$23.95M

Damodaran Growth Analysis (4)

Reinvestment Rate:-334.3%

Fundamental Growth Rate (g):-11.9%

Market-Implied Growth Rate:-3.5%

Brina Gap:

-8.4%

☷ Click to view full HYPD Brina Gap analysis →

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-25.9%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-42.1%

Book Value Growth Rate (Linear):37.0%

C. Company Profile & Context

Corporate Information (6)

Symbol:HYPD

Company Name:HYPERION DEFI, INC.

Sector:Healthcare

Industry:Pharmaceuticals

Exchange:NASDAQ

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:low

Volume Category:N/A

Share Structure (3)

Shares Outstanding:14.17M

Shares Outstanding Basic:14.17M

Shares Outstanding Diluted:17.04M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-09-01 05:40:15 UTC

Data Timestamp:2026-08-20T15:52:50.629382